Skip to search formSkip to main contentSkip to account menu

Org 25969

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Sugammadexsugammadex sodium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
[Efficacy and safety of sugammadex (Org 25969) in reversing deep neuromuscular block induced by rocuronium or vecuronium in Japanese patients].
BACKGROUND Efficacy and safety of sugammadex in reversing neuromuscular block induced by rocuronium or vecuronium were… 
2006
2006
First human exposure to Org 25969.
about the reversal of rocuronium-induced neuro-muscular block by Org 25969. The described reversal mechanism ishighly promising… 
Review
2006
Review
2006
[Sugammadex (Org 25969, modified gamma-cyclodextrin)].
Sugammadex, a chemically modified gamma-cyclodextrin, was synthesized as a selective reversal agent for rocuronium, a steroidal… 
2005
2005
Reversal of high-dose rocuronium with Org 25969: A-458
2002
2002
Liquid chromatography/mass spectrometric bioanalysis of a modified gamma-cyclodextrin (Org 25969) and Rocuronium bromide (Org 9426) in guinea pig plasma and urine: its application to determine the…
A sensitive and specific liquid chromatography/mass spectrometry (LC/MS) method has been developed and validated for the… 
2002
2002
Org 25969 Causes Rapid Reversal of Rocuronium-Induced Neuromuscular Block, Independent of Acid-Base Status: [2002][A-1009]
2001
2001
Chemical chelation as a novel method of NMB reversal - discovery of Org 25969: 16
2001
2001
Org 25969 reverses rocuronium-induced neuromuscular blockade in the cat without important haemodynamic effects: 17
2001
2001
Neuromuscular blockade induced by steroidal NMBs can be rapidly reversed by Org 25969 in the anaesthetized monkey: 19
2001
2001
org 25969 causes selective reversal of neuromuscular blockade induced by steroidal Nmbs in the mouse hemi-diaphragm preparation : 20
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)